Organization

Rheumatology, University of Manitoba, Winnipeg

1 abstract

Abstract
A SUBSTANTIAL PROPORTION OF PATIENTS FAILING TO ACHIEVE DAS28 OR ACR20 RESPONSE AT 12 WEEKS OF DMARD THERAPY EXHIBIT IMPROVEMENT IN CORE SET MEASURES. RESULTS FROM AN EARLY ARTHRITIS COHORT
Org: Rheumatology, University of Toronto, Toronto, Canada, Rheumatology, Brigham and Women's Hospital, Boston, United States, Mount Sinai Hospital, Toronto, Canada, Rheumatology, University of Sherbrook, Sherbrook, Rheumatology, 9Southlake Regional Health Centre, Newmarket,